Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

Carvacrol activates the TRPV3 channel, which may help design new skin treatments.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

TPA is about 50 times more effective at promoting tumors than MZ.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Baricitinib can cause excessive hair growth.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Both steroids, especially cyproterone acetate, harm quail's vital organs.

Tazarotene gel is more effective for acne than tretinoin and works as well as adapalene.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

The compound 4c showed strong potential as an anticancer agent.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Baricitinib helps patients with severe alopecia areata regrow hair.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.